title: Carbamazepine and its metabolites in human perfused placenta and in maternal and cord blood.
abstract: Placental transfer and metabolism of carbamazepine (CBZ) was studied in a dual recirculating placental cotyledon perfusion system and was also evaluated in 16 pairs of maternal venous and cord blood samples. Among the parameters studied as possible indicators of a successful perfusion, volume changes in perfusate divided the perfusions into two groups, whereas no significant differences between perfusions were noted in blood gas analysis or in antipyrine transfer. CBZ added into the maternal circulation crosses the placenta in the beginning quicker than antipyrine which is in agreement with the different lipid solubilities of these compounds. Because the transfer rates of antipyrine and CBZ were about the same, the mechanism of transfer of CBZ is probably similar to that of antipyrine (passive diffusion). No metabolites of CBZ could be detected in the perfusate by high-performance liquid chromatography (HPLC) or gas chromatography/mass spectrometry. With the improved HPLC methodology for CBZ metabolites, six metabolites were detected in clinical samples, including 10-hydroxy-10,11-dihydro-CBZ (10-OH-CBZ), which has been described earlier in only 1 uremic patient. Relative levels of metabolites showed significant individual differences. CBZ crosses perfused placenta rapidly, but this does not contribute to CBZ metabolites detected in maternal and fetal circulation.
authors.affiliation: Department of Pharmacology and Toxicology, University of Oulu, Finland.
authors.forename: P
authors.initials: P
authors.lastname: Pienimäki
authors.forename: A L
authors.initials: AL
authors.lastname: Hartikainen
authors.forename: P
authors.initials: P
authors.lastname: Arvela
authors.forename: T
authors.initials: T
authors.lastname: Partanen
authors.forename: R
authors.initials: R
authors.lastname: Herva
authors.forename: O
authors.initials: O
authors.lastname: Pelkonen
authors.forename: K
authors.initials: K
authors.lastname: Vähäkangas
mesh_terms: D000983:Antipyrine / Q000378:metabolism / Q000493:pharmacokinetics; D001692:Biological Transport; D001769:Blood / Q000378:metabolism*; D002220:Carbamazepine / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics*; D002849:Chromatography, Gas; D002851:Chromatography, High Pressure Liquid; D005260:Female; D005312:Fetal Blood / Q000378:metabolism*; D006801:Humans; D013058:Mass Spectrometry; D008431:Maternal-Fetal Exchange; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy
chemical_list: C039775:10,11-dihydro-10-hydroxycarbamazepine; D002220:Carbamazepine; D000983:Antipyrine